Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Leiomyoma: full-pipeline trial registry
4 of 9 indexed Leiomyoma trials are currently recruiting.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Leiomyoma: 9 US clinical trials tracked, 4 recruiting.
Leiomyoma is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 2 of these trials.
Enrollment posture brief
Registry condition leiomyoma
OPEN 4 | RECR 44% | LATE 3 | EARLY 3 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Leiomyoma lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Leiomyoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Leiomyoma is recruiting below its size-band peers.
4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Leiomyoma research.
Johns Hopkins University accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Leiomyoma enrolment sits around 72 participants.
Median target enrolment is 72 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Leiomyoma research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Johns Hopkins University
NCT06135870
Prescription of Letrozole for Uterine Myoma
University of California, San Francisco
NCT06143631
Effects of Simvastatin on Uterine Leiomyoma Size
Johns Hopkins University
NCT03400826
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Zenchi
NCT07078682
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Allergan
NCT02147197
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
University of Texas Southwestern Medical Center
NCT01793584
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00290251
Trial of Mifepristone for Fibroids
University of Rochester
NCT00133705
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT00044876
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Leiomyoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Leiomyoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Leiomyoma page
9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Leiomyoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Johns Hopkins University sponsors the most Leiomyoma trials on record, review their full trial history before evaluating a specific study. See Johns Hopkins University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Leiomyoma condition card totals 9 registered trials; most-linked intervention Inert Capsule; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.